Hemodialysis Market Share, Size, Trends, Industry Analysis Report, By Product (Device, Consumables, Service); By End-Use (Home-based, Hospital-based); By Dialysis Type; By Region; Segment Forecast, 2022 - 2030
- Published Date:Sep-2022
- Pages: 118
- Format: PDF
- Report ID: PM2564
- Base Year: 2021
- Historical Data: 2018-2020
Report Outlook
The global Hemodialysis market was valued at USD 75.28 billion in 2021 and is expected to grow at a CAGR of 7.0% during the forecast period. The major factors such as the approval of innovative products and consumables by regulatory bodies, the involvement of public authorities in the prevention and control of renal diseases, and the cooperative efforts of numerous organizations to provide effective renal services in the specialized areas of developing regions will all contribute to the hemodialysis market's expansion.
Know more about this report: Request for sample pages
Dialysis is a treatment used to eliminate waste products from the blood, such as urea and creatinine, as a result of poor kidney function; it is commonly required for those with chronic renal failure. The process is important for a kidney transplant. During this procedure, the electrolyte balance is recovered, the blood is purified, and superfluous fluid and toxins are removed.
There are two ways to perform dialysis, including hemodialysis and peritoneal dialysis. During hemodialysis, waste products like urea are removed extracorporeal from the patient's circulation. In peritoneal dialysis, the membrane in the stomach is used for the dialysis process.
The coronavirus outbreak is currently providing several challenges for patients and clinical healthcare providers everywhere in the world. The rise in COVID cases and the severity rate are expected to have an impact on an increase in the number of renal injuries. The worldwide need for renal replacement fluids has risen as a result of the outbreak.
When compared to previous US populations, the need for RRT has increased fivefold in COVID-19 patients. Home hemodialysis therapy had been on the rise before the pandemic, and patients' interest in HD therapy has greatly grown due to worries about the COVID-19 virus's spread. This factor will push people to use home hemodialysis equipment when the pandemic strikes.
Know more about this report: Request for sample pages
Industry Dynamics
Growth Drivers
Chronic kidney disease (CKD) causes damage to the kidneys, which may eventually make them less effective in removing waste products from the blood than healthy kidneys. Ineffective kidneys cause the body to amass toxic waste and extra fluid, which can cause high blood pressure, heart disease, stroke, and early death. However, those who have CKD or are at risk of developing it can take precautions to safeguard their kidneys with the assistance of their medical professionals.
The prevalence of CKD has significantly increased, which is driving the market demand for quick-access renal facilities. As per the CDC, chronic kidney disease affects 15% of adults in the US, or around 37 million people. There are 37 million adults in the US, or 15% of the population, who have CKD. Up to 90% of persons with CKD are unaware of their condition. Nearly 25% of persons with severe CKD are unaware of their condition.
Further, the number of renal care centers has grown in industrialized nations as a result of the availability of highly qualified nephrologists. Additionally, investors are concentrating more on expanding renal treatment facilities in nations like India, China, Mexico, etc., to meet the growing need for renal care in emerging economies. In the next years, this is anticipated to fuel the hemodialysis market's revenue generation. The number of visits to these facilities is rising as a result of the accessible healthcare provided in these nations.
Report Segmentation
The market is primarily segmented based on product, dialysis type, end-use, and region.
|
By Product |
By Dialysis Type |
By End-Use |
By Region |
|
|
|
|
Know more about this report: Request for sample pages
Hemodialysis segment is expected to witness the fastest market growth
The hemodialysis market is further divided into two categories, including traditional, brief daily hemodialysis and nighttime hemodialysis. A hemodialyzer is used during hemodialysis to eliminate excess and waste chemicals and fluids from the body. As the blood goes through the filter, it comes into touch with dialysate, which resembles physiological fluid except for the presence of contaminants.
In addition, this type of dialysis is rather complex, requiring a rigid treatment plan and having little room for patient mobility, time, or transportation. To access the high blood flows necessary for dialysis it also involves setting up and maintaining vascular access, such as a dialysis catheter or the creation of an AV fistula or graft in the arm or groyne.
Key drivers include a rise in ESRD patients, a growth in the elderly population with kidney diseases, and an increase in the frequency of hypertension. The market growth is anticipated to be greatly accelerated by the aging population and the increased risk of CKD.
Services segment industry accounted for the highest market share in 2021
Services made up the largest portion of sales, mostly as a result of the development of modern renal care facilities for both chronic and emergency treatment around the world and service providers' increasing emphasis on providing patients with high-quality care. Additionally, the market demand for services is growing as a result of the service providers' enhanced business models, which are patient-centric and profit-driven.
The major player's key activities and technological advancements are anticipated to further accelerate hemodialysis market expansion. For instance, in February 2021, DaVita launched a telehealth solution named DaVita Care Connect for its home dialysis business. It was just one of the numerous connected technologies that were incorporated into its service portfolio to improve treatment and outcomes for patients who choose to self-care at home.
During the projection period, the consumables category is anticipated to grow at the greatest CAGR. Governments are anticipated to make large investments to improve patient safety and efficacy. Reducing the likelihood of malfunction can help catheters last longer.
Additionally, there is a growing market demand for hemodialysis for catheters with an antibacterial coating, reducing the likelihood of infections caused. Similar to how new membrane dialyzers for better diffusion and better surface contact have a positive effect on the expansion of the consumable segment, so do new production technologies for membrane dialyzers.
Hospital-based segment is expected to hold the significant revenue share
The substantial supply of highly skilled and seasoned healthcare staff at hospitals will likely allow the industry to maintain its lead over the coming years. The presence of a skilled and knowledgeable renal medical team in healthcare settings, including hospitals and dialysis clinics, ensures successful treatment and enhanced dialysis results.
This is due to the advantageous reimbursement renal facilities and hospitals give for renal therapies, the growing patient population suffering from CKD and ESRD, and the population's rising healthcare spending.
The demand in North America is expected to witness significant market growth
The major factors expected to drive the market demand for hemodialysis during the forecast period are the high prevalence of CKD and ESRD in the U.S. and Canada and increased treatment rates in these nations. Due to the rising number of coronavirus infections and the ensuing renal failures, the U.S. is also expected to experience a rise in the market demand for the products and services.
As the second-largest region in terms of market size, Europe is predicted to experience moderate growth over the long run. The region's high rate of senior population living from renal ailments is mostly to blame for the market growth. The older population in Brazil is experiencing an increase in the prevalence of CKD, which is fueling the expansion of the services and goods industry.
Additionally, rising renal failure cases, an aging population, and increased product development are anticipated to fuel market expansion for hemodialysis throughout the projected period. In addition, the IDF estimates that 88 million adults in the South East Asian market currently have diabetes, with 153 million likely to have the disease by 2045. In addition, rising government programs, CKD awareness programs, the availability of newly built advanced health care facilities in the area, and growing health expenditures are a few other factors influencing the market growth for hemodialysis.
Competitive Insight
Some of the major players operating in the global hemodialysis market include Asahi Kasei Corporation, AWAK Technologies Inc., Allmed Medical Care Corporation, AngioDynamics LLC, B. Braun Melsungen AG, Becton, Dickinson & Company, Baxter International, Dialife S.A., Fresenius SE & Co. KGaA, Hemoclean Co., Ltd., Medtronic Plc, Nipro Corporation, Nikkiso Co., Ltd., Outset Medical, Inc., Quanta Dialysis Technologies, Toray Medical Co. Ltd., and Teleflex, Inc.
Recent Developments
In June 2021, Baxter International Inc. has introduced Sharesource Analytics 1.0, the next-generation eHealth solution for peritoneal dialysis (PD) patients receiving care at home. This technological advancement is a clinical management tool included in the Sharesource remote patient monitoring system that gives medical practitioners complete information about the treatment of their home dialysis patients
Hemodialysis Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2021 |
USD 75.28 billion |
|
Revenue forecast in 2030 |
USD 136.86 billion |
|
CAGR |
7.0% from 2022 - 2030 |
|
Base year |
2021 |
|
Historical data |
2018 - 2020 |
|
Forecast period |
2022 - 2030 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2022 to 2030 |
|
Segments Covered |
By Product, By Dialysis Type, By End-Use, By Region |
|
Regional scope |
North America, Europe, Asia Pacific, Latin America; Middle East & Africa |
|
Key Companies |
Asahi Kasei Corporation, AWAK Technologies Inc., Allmed Medical Care Corporation, AngioDynamics LLC, B. Braun Melsungen AG, Becton, Dickinson & Company, Baxter International, Dialife S.A., Fresenius SE & Co. KGaA, Hemoclean Co., Ltd., Medtronic Plc, Nipro Corporation, Nikkiso Co., Ltd., Outset Medical, Inc., Quanta Dialysis Technologies, Toray Medical Co. Ltd., and Teleflex, Inc. |
